| 吕一帆,刘福全.经颈静脉肝内门体分流术后抗凝治疗现状[J].中国介入影像与治疗学,2021,18(10):622-626 |
| 经颈静脉肝内门体分流术后抗凝治疗现状 |
| Status of anticoagulant therapy after transjugular intrahepatic portosystemic shunt |
| 投稿时间：2021-04-14 修订日期：2021-08-27 |
| DOI：10.13929/j.issn.1672-8475.2021.10.011 |
| 中文关键词: 门体分流术,经颈静脉肝内 支架 抗凝治疗 |
| 英文关键词:portasystemic shunt, transjugular intrahepatic stents anticoagulant therapy |
| 基金项目: |
|
| 摘要点击次数: 1024 |
| 全文下载次数: 285 |
| 中文摘要: |
| 经颈静脉肝内门体分流术（TIPS）可治疗门静脉高压，但术后常发生分流道狭窄或闭塞。TIPS术后抗凝治疗可预防支架内血栓形成，但同时增加出血风险，且目前尚缺乏统一标准。本文就TIPS术后抗凝治疗现状进行综述。 |
| 英文摘要: |
| Transjugular intrahepatic portosystemic shunt (TIPS) could be used to treat portal hypertension, but shunt stenosis or occlusion often occurred after TIPS procedures. Anticoagulant therapies after TIPS could prevent stent thrombosis, but also increase the risk of bleeding, which were found without unified standards. The status of anticoagulant therapy after TIPS was reviewed in this article. |
| 查看全文 查看/发表评论 下载PDF阅读器 |
| 关闭 |
